Sex‐based differences in biomarkers, health status, and reverse cardiac remodelling in patients with heart failure with reduced ejection fraction treated with sacubitril/valsartan
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Sex‐based differences in biomarkers, health status, and reverse cardiac remodelling in patients with heart failure with reduced ejection fraction treated with sacubitril/valsartan
Authors
Keywords
-
Journal
EUROPEAN JOURNAL OF HEART FAILURE
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2020-09-18
DOI
10.1002/ejhf.2005
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cellular and Molecular Differences between HFpEF and HFrEF: A Step Ahead in an Improved Pathological Understanding
- (2020) Steven J. Simmonds et al. Cells
- A putative placebo analysis of the effects of sacubitril/valsartan in heart failure across the full range of ejection fraction
- (2020) Muthiah Vaduganathan et al. EUROPEAN HEART JOURNAL
- Differential Impact of Heart Failure With Reduced Ejection Fraction on Men and Women
- (2019) Pooja Dewan et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Adverse Drug Reactions to Guideline-Recommended Heart Failure Drugs in Women
- (2019) Sophie H. Bots et al. JACC-Heart Failure
- Association of Change in N-Terminal Pro–B-Type Natriuretic Peptide Following Initiation of Sacubitril-Valsartan Treatment With Cardiac Structure and Function in Patients With Heart Failure With Reduced Ejection Fraction
- (2019) James L. Januzzi et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Imaging, Biomarker, and Clinical Predictors of Cardiac Remodeling in Heart Failure With Reduced Ejection Fraction
- (2019) Alberto Aimo et al. JACC-Heart Failure
- Effects of Sacubitril-Valsartan, versus Valsartan, in Women Compared to Men with Heart Failure and Preserved Ejection Fraction: Insights from PARAGON-HF
- (2019) John J. V. McMurray et al. CIRCULATION
- Sex differences in heart failure
- (2019) Carolyn S P Lam et al. EUROPEAN HEART JOURNAL
- Rationale and methods of the Prospective Study of Biomarkers, Symptom Improvement, and Ventricular Remodeling During Sacubitril/Valsartan Therapy for Heart Failure (PROVE-HF)
- (2018) James L. Januzzi et al. AMERICAN HEART JOURNAL
- Participation of Women in Clinical Trials
- (2018) Louise Pilote et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Temporal trends and patterns in heart failure incidence: a population-based study of 4 million individuals
- (2018) Nathalie Conrad et al. LANCET
- Prognostic Value of Serial ST2 Measurements in Patients With Acute Heart Failure
- (2017) Laura C. van Vark et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Effect of Sex on Reverse Remodeling in Chronic Systolic Heart Failure
- (2017) Alberto Aimo et al. JACC-Heart Failure
- 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
- (2016) Piotr Ponikowski et al. EUROPEAN JOURNAL OF HEART FAILURE
- Sex-specific cardiovascular structure and function in heart failure with preserved ejection fraction
- (2014) Mauro Gori et al. EUROPEAN JOURNAL OF HEART FAILURE
- Angiotensin–Neprilysin Inhibition versus Enalapril in Heart Failure
- (2014) John J.V. McMurray et al. NEW ENGLAND JOURNAL OF MEDICINE
- Health-Related Quality of Life After Transcatheter Aortic Valve Replacement in Inoperable Patients With Severe Aortic Stenosis
- (2011) Matthew R. Reynolds et al. CIRCULATION
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now